Medical Weight Loss

Semaglutide is FDA-approved for chronic weight management in adults who are classified as overweight or obese. The hormone-based therapy works by mimicking the glucagon-like peptide-1 (or GLP-1) and increasing insulin secretion, which results in appetite suppression and delayed gastric emptying, causing you to feel fuller longer. As a result, you to eat less and ultimately lose weight. Semaglutide is also helpful in decreasing body fat and lowering HbA1C, which is key for diabetes prevention and combating a host of other chronic conditions.

Semaglutide is simple and accurate to self-administer in one weekly subcutaneous injection, making it all the more convenient and effective when used as part of an overall medical weight loss plan that includes nutrition management and physical activity.

Average weight loss is 8-14 lbs/month, but results can vary based on the individual. Recommended treatment is 6-9 months for active weight loss, followed by ongoing maintenance, indefinitely at a lower dose.

Semaglutide should not be taken by those with a personal or family history of medullary thyroid carcinoma (MTC) or by individuals with history of Multiple Endocrine Neoplasia syndrome type 2, an endocrine tumor syndrome that can involve the adrenal, parathyroid gland and thyroid glands

The brand names of Semaglutide (Wegovy®, Ozempic®) can run anywhere from $1,300 to $1,500 a month and is often not covered by insurance. Muse, however, is able to offer an affordable monthly option from our partner compounding pharmacy who will ship the medication directly to your home.